INSIGHTS ON CLINICAL TRIAL PARTNERING

• ATLAS Label Translation Solution

  By simplifying label requests, integrating expert translation and regulatory support, and enabling a fully paperless approval workflow, organizations can reduce turnaround times while maintaining high-quality label content.

• Prospecting Biospecimen Collections To Power Precision Medicine

  High-quality biospecimens are the foundation of precision medicine success. Learn the five crucial steps—from planning to compliance—for a prospective biospecimen collection that is scientifically robust and accelerates your research.

• Strong Bookings And The Disruption Gap Nobody Is Talking About

  Understand the real impact of AI on CRO valuations and clinical trial stability. Explore why market data contradicts the "disruption" narrative and what it means for the future of the industry.

• The Evolution Of GLP-1s: Overcoming Clinical Development Challenges

  Explore clinical development trends, recruitment hurdles, study design strategies, and emerging therapies shaping obesity and metabolic disease research.

• How Sponsors, CROs, And Tech Vendors Can Reduce Site Tech Overload

  10/10/2024

  Sites juggle dozens of applications, which increases their workload and limits their capacity. Sites need an industry-wide single sign-on experience that brings key systems and applications under one roof.

• Breaking Down Early Small Molecule Development

  3/11/2026

  Adopt an integrated development strategy to streamline the path from early development to the clinic, ensuring timely clinical supply while reducing delays, risk, and inefficiencies.

• Technology Fragmentation Is One Of The Biggest Hidden Risks In Clinical Trials

  4/6/2026

  Reclaim your research day by reducing manual data entry. Learn how connecting operational and financial workflows eases administrative burdens and supports site sustainability.

• Building Recruitment Into Early-Phase Trial Design

  7/30/2026

  Successful recruitment starts with smart study design. Early recruitment insight improves feasibility, supports realistic timelines, and reduces enrollment risk.

• The Silent Saboteurs: Why Rater Drift And Site Unpreparedness Cost CNS Trials More

  3/25/2026

  High-end technology cannot fix poor rater preparation or complex patient needs. True data integrity requires bridging the gap between digital platforms and the reality of clinical implementation.